Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Spotlight on Biogen
Motley Fool
Friday, April 6, 2012 - 11:11am
tags:
Biogen Idec
Are These 2 Biotechs About to Be Bought?
Motley Fool
Friday, April 6, 2012 - 9:44am
tags:
M&A, Bristol-Myers Squibb, Amarin, Amylin
Amgen, Abbott, Teva All Incredibly Undervalued Stocks
Seeking Alpha
Friday, April 6, 2012 - 9:39am
tags:
Amgen, Teva Pharmaceuticals, Abbott Laboratories, Bristol-Myers Squibb
Takeda says likely to get 57 bln yen tax refund after appeal
Reuters
Friday, April 6, 2012 - 9:37am
tags:
Takeda, tax refund, transfer pricing
'Animal rule' allowed for J&J drug backed for new approval
Fierce Pharma
Thursday, April 5, 2012 - 9:18pm
tags:
JNJ, Levaquin, antibiotics
Spectrum Declines After Bladder Cancer Drug Fails in Study
Bloomberg
Thursday, April 5, 2012 - 9:15pm
tags:
bladder cancer, Spectrum Pharmaceuticals, apaziquone
4 Biotechs Struggling Due To High Drug Costs
Seeking Alpha
Thursday, April 5, 2012 - 9:14pm
tags:
Pfizer, Dendreon, Cell Therapeutics, Exelixis
Krill Oil Based Drug Candidate Could Unseat Glaxo's Blockbuster Loveza
Seeking Alpha
Thursday, April 5, 2012 - 9:13pm
tags:
GSK, Loveza, krill oil, Pfizer, Neptune Biopharma, Acasti
Priority Review for Zaltrap
Yahoo/Zacks
Thursday, April 5, 2012 - 9:12pm
tags:
Zaltrap, Regeneron, Sanofi, colorectal cancer
Vivus' ED Drug Will Make Investors Money
Motley Fool
Thursday, April 5, 2012 - 9:11pm
tags:
erectile dysfunction, Vivus, Avanafil
Expensive Celgene Shares A Better Bet Than Most Biotechs
Seeking Alpha
Thursday, April 5, 2012 - 9:10pm
tags:
Celgene, JNJ, ONYX Pharmaceuticals, Revlimid, Pfizer
Astellas Wins FDA Panel Backing for Overactive Bladder Drug
Bloomberg
Thursday, April 5, 2012 - 9:07pm
tags:
FDA, overactive bladder, Astellas, mirabegron
Teva Active on the Generics Front
Yahoo/Zacks
Thursday, April 5, 2012 - 9:06pm
tags:
generics, Teva Pharmaceuticals, Sanofi, AstraZeneca, Avapro, Avalide, Lexapro, Forest Labs, Seroquel
Does Novo Nordisk's Pipeline Justify Its Premium?
Seeking Alpha
Thursday, April 5, 2012 - 9:04pm
tags:
Novo Nordisk
Lpath: A Solid Pipeline With Good PPS
Seeking Alpha
Thursday, April 5, 2012 - 7:38pm
tags:
Lpath, Pfizer, Merck, bioactive lipids
Pfizer Will Trim Benefits for Fired Workers in Cost-Cutting
Bloomberg
Thursday, April 5, 2012 - 7:37pm
tags:
Pfizer, severance
Allos to be acquired by Spectrum Pharma for $206M
Marketwatch
Thursday, April 5, 2012 - 8:42am
tags:
M&A, Spectrum Pharmaceuticals, Allos
Arena: Which Way, Up Or Down?
Seeking Alpha
Thursday, April 5, 2012 - 8:41am
tags:
Arena, obesity, lorcaserin
Myriad Study to Benefit Colaris
Yahoo/Zacks.com
Wednesday, April 4, 2012 - 11:22pm
tags:
Colaris, Myriad Genetics, colon cancer
U.S. drug spending up, thanks to new drug launches
Fierce Pharma
Wednesday, April 4, 2012 - 11:11pm
tags:
drug launches, prescription data

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.